Inogen Medical - INGN Net Assets per Single Share

Inogen, Inc. (INGN) generates revenue from the sale of portable oxygen concentrators, having transitioned to a direct-to-consumer sales model that delivers significant profit. However, the business faces intense pressure from low-cost Eastern alternatives and industry behemoths, necessitating the protection of its intellectual property. The current metric stands at 6.56. The price chart below reflects risks associated with reduced Medicare reimbursements and potential technological obsolescence.

Amid severe pricing pressure from Asian portable concentrator manufacturers, Inogen, Inc. must maintain a high net asset value to remain competitive. This aggregate book value reflects the residual capital per share after all liabilities are settled, serving as a hard indicator of investor liquidation protection in the event of negative business scenarios.